Experts discuss Prosigna-guided treatment decisions in high-risk early disease ...

Did you know that a simple genetic test called DNA testing is all that is needed to understand if you are at risk of ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

The Prosigna genomic test may help identify breast cancer patients who are likely to gain little benefit from chemotherapy ...

Population-based pathogenic variant testing identified breast cancer susceptibility gene carriers who would often be missed ...

Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes ...

For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

Next-generation sequencing is widely regarded as a transformative technology that delivers potentially life-prolonging therapies to patients with advanced cancers. Yet the testing is still underused ...

It was this oncologist who had a very different recommendation: Try the Oncotype DX Breast Recurrence Score® test, a ...

Patient-centered education and navigation support increase consent rates for genomic testing, aiding integration into cancer care and access to genomics-based trials. The SURGE study underscores the ...

EXCLUSIVE: Cancer Research UK is funding hundreds of genetic tests to personalise cancer treatment.